Best Healthcare Market Research Companies in Peru (2026 Guide)
An independent guide to the leading healthcare market research companies operating in Peru for 2026. This guide profiles 5 firms across pharmaceutical research, DIGEMID regulatory intelligence, SIS and EsSalud reimbursement studies, HEOR, and competitive intelligence — comparing capabilities and Peru-specific expertise to help you select the right healthcare research partner in this rapidly growing Andean market.
Published 2026-06-11 · By BioNixus Research Team
5
Firms Profiled
$3B+
Pharma Market
DIGEMID-Regulated
8
FAQs Answered
Best Healthcare Market Research Companies in Peru (2026)
The following healthcare market research companies have demonstrated operations or project delivery in Peru as of 2026, covering pharmaceutical, regulatory, public health insurance, and health economics research:
- 1BioNixus — Best for: Peru and South America healthcare research execution, DIGEMID regulatory awareness, SIS/EsSalud market access intelligence, and Spanish-English bilingual delivery
- 2IQVIA Peru — Best for: IMS pharma data, pharmaceutical market measurement, real-world evidence, sales force effectiveness
- 3Ipsos Healthcare (Peru Coverage) — Best for: quantitative and qualitative pharmaceutical research, physician and patient surveys, consumer health studies
- 4Kantar Health (LATAM) — Best for: consumer health tracking, patient behaviour research, health and wellness insights across LATAM
- 5Euromonitor International — Best for: syndicated market sizing, Peru country reports, consumer health category intelligence, five-year forecasts
Peru Healthcare Market Research Landscape 2026
Peru is an important and fast-growing pharmaceutical market in Latin America, valued at over $3 billion USD and expanding at approximately 7-9% annually. Driven by a population of over 33 million across a diverse geographic and cultural landscape, Peru presents distinct challenges and opportunities for healthcare market research. Lima concentrates the majority of pharmaceutical activity, multinational affiliates, and specialist physician networks, while the interior and high-altitude regions present underserved populations with distinct disease profiles and access challenges.
DIGEMID (Dirección General de Medicamentos, Insumos y Drogas) operates under MINSA (Ministerio de Salud) as Peru's primary pharmaceutical regulatory authority, overseeing drug registration, clinical trial authorisation, and pharmacovigilance. Peru's public health coverage is split between SIS (Seguro Integral de Salud) — which targets low-income and vulnerable populations — and EsSalud (Seguro Social de Salud del Perú), which provides social health insurance to formal-sector workers and their families. Together, these systems cover the majority of the population, though out-of-pocket expenditure remains significant for innovative and branded therapies.
Peru faces a substantial disease burden including high rates of tuberculosis (one of the highest in the Americas), diabetes, cardiovascular disease, and cancer. Growing clinical trial activity and Lima's emergence as a LATAM pharma hub have increased demand for high-quality primary healthcare research. Peru's multicultural population — Spanish and Quechua-speaking communities across diverse geographic zones — requires culturally sensitive research design and fieldwork protocols. The right healthcare research partner must combine DIGEMID regulatory knowledge, SIS/EsSalud system awareness, and genuine Peru-specific fieldwork capability.
5 Healthcare Market Research Companies in Peru (2026)
Firms are assessed by use case and market positioning — select based on your research type, sector, and in-country requirements.
BioNixus
Best for: Peru and South America healthcare research execution, DIGEMID regulatory awareness, SIS/EsSalud market access intelligence, and Spanish-English bilingual delivery
BioNixus is a global healthcare and market research firm headquartered in the USA with offices in the UK and the Middle East, delivering comprehensive pharmaceutical and healthcare market research across Peru and South America. With 15+ years of experience serving 48+ global clients across 17+ countries, BioNixus brings pharmaceutical usage and attitude studies, KOL identification and mapping, physician panel surveys, DIGEMID regulatory awareness, SIS/EsSalud reimbursement intelligence, HEOR, and competitive intelligence to the Peru market. BioNixus executes fully bilingual Spanish-English research with awareness of Peru's fragmented multi-payer healthcare architecture and MINSA public health priorities. As a global firm comparable in scope to IQVIA and Ipsos Healthcare, BioNixus offers multinational pharma and biotech companies rigorous, decision-ready healthcare research quality across all therapeutic areas relevant to the Peruvian market.
Key strengths
- Full-service pharmaceutical U&A, KOL mapping, and physician surveys for Peru
- DIGEMID regulatory awareness and MINSA public health sector intelligence
- SIS and EsSalud formulary pathway research and reimbursement intelligence
- Spanish-English bilingual field execution in Lima and Peru's regional centres
- HEOR and health economics research for the Andean region market
- Peru and South America competitive intelligence and regional benchmarking
IQVIA Peru
Best for: IMS pharma data, pharmaceutical market measurement, real-world evidence, sales force effectiveness
IQVIA serves Peru through its LATAM regional network, providing IMS prescription and sales data, pharmaceutical market measurement, and real-world evidence programmes for the Peruvian market. IQVIA's MIDAS database offers granular pharmaceutical tracking across public (EsSalud, SIS) and private pharmacy channels in Peru. Their commercial analytics and consulting capabilities support market access strategy and sales force optimisation for multinational pharma clients operating in Peru.
Key strengths
- IMS pharma data and market measurement for Peru
- Real-world evidence and outcomes research
- Sales force effectiveness and commercial analytics
- LATAM multi-market benchmarking capability
Ipsos Healthcare (Peru Coverage)
Best for: quantitative and qualitative pharmaceutical research, physician and patient surveys, consumer health studies
Ipsos operates in Peru through its Lima office, delivering quantitative surveys, qualitative research, and digital healthcare studies across pharmaceutical and consumer health categories. Ipsos Peru supports multinational pharma clients with physician perception studies, patient journey mapping, brand tracking, and treatment decision research. Their Lima-based fieldwork team provides access to Peru's specialist physician community and urban consumer health populations.
Key strengths
- Quantitative and qualitative pharmaceutical surveys for Peru
- Physician and patient research across key therapeutic areas
- Brand tracking and consumer health studies
- Urban Lima-focused primary fieldwork capability
Kantar Health (LATAM)
Best for: consumer health tracking, patient behaviour research, health and wellness insights across LATAM
Kantar Health covers Peru and the broader Latin America region through its LATAM research network, applying global panel infrastructure for consumer health, patient behaviour, and wellness tracking. Kantar's Peru engagements support pharmaceutical and consumer health clients with adherence research, patient support programme evaluation, and health behaviour studies. Their regional positioning enables direct Peru-to-LATAM benchmarking for comparative market analysis.
Key strengths
- Consumer health and patient behaviour tracking
- Health and wellness consumer segmentation
- Patient adherence and behaviour research
- LATAM regional benchmarking and multi-country studies
Euromonitor International
Best for: syndicated market sizing, Peru country reports, consumer health category intelligence, five-year forecasts
Euromonitor International provides syndicated market intelligence for Peru across healthcare, consumer health, and consumer goods categories through its Passport database. Euromonitor offers market sizing, competitive landscape analysis, and five-year forecasts for OTC healthcare, personal care, and related consumer categories in Peru. Euromonitor does not conduct custom primary research — their value lies in standardised market data for market entry assessment, category benchmarking, and competitive intelligence across Peru and the wider Andean region.
Key strengths
- Syndicated Peru market data and country intelligence reports
- Consumer health and OTC category market sizing
- Five-year market forecasts and trend analysis
- Andean region and South America multi-country intelligence
Peru Healthcare Market Research Capabilities Comparison
| Capability | BioNixus | IQVIA Peru | Ipsos Healthcare | Kantar Health | Euromonitor |
|---|---|---|---|---|---|
| Custom primary research (qual + quant) | Full-service | Selective / analytics-led | Full-service | Full-service | None (syndicated only) |
| DIGEMID regulatory awareness | Yes | Yes | Partial | Limited | No |
| Physician & KOL recruitment | Yes | Yes | Yes | Limited | No |
| SIS/EsSalud reimbursement research | Yes | Yes | Partial | Limited | No |
| Spanish-English bilingual delivery | Standard | Standard | Standard | Standard | Reports only |
| Syndicated pharma market data | Via custom research | IMS/MIDAS full portfolio | Limited | Consumer health panels | Full portfolio |
Key Considerations for Healthcare Market Research in Peru
DIGEMID Regulatory Landscape
DIGEMID (Dirección General de Medicamentos, Insumos y Drogas) under MINSA is Peru's primary pharmaceutical regulator, overseeing drug registration, clinical trial authorisation, and pharmacovigilance. Peru has been actively modernising its regulatory framework to align with WHO and PIC/S standards, though regulatory timelines can be longer than in Chile or Colombia. Research supporting DIGEMID submissions or public sector formulary inclusion in EsSalud's national formulary must account for Peru's specific evidence requirements and procurement processes.
Peru's Diverse and Fragmented Healthcare Landscape
Peru's healthcare system is among the most fragmented in Latin America, combining MINSA (public health ministry), EsSalud (social health insurance for formal workers), SIS (targeted insurance for vulnerable populations), FFAA/PNP (armed forces and police coverage), and a substantial private sector. This fragmentation, combined with significant geographic disparities between Lima and the interior highlands and jungle regions, creates complex sampling and access challenges for healthcare research. Multicultural patient populations — including Spanish and Quechua-speaking communities — require culturally adapted research instruments and experienced local fieldwork partners.
LATAM Growth Market Opportunity
Peru's pharmaceutical market is growing faster than the regional average, driven by a rapidly expanding middle class, increasing chronic disease burden, and growing clinical trial activity that positions Lima as an emerging LATAM research hub. For multinational pharma companies, Peru represents both a standalone commercial opportunity and a valuable component of broader Andean region evidence packages. Selecting a research partner with Peru depth and broader LATAM execution capability enables efficient evidence generation across Peru, Colombia, Ecuador, and Bolivia simultaneously.
Frequently Asked Questions
What are the best healthcare market research companies in Peru?
Leading healthcare market research companies in Peru include BioNixus, IQVIA Peru, Ipsos Healthcare, Kantar Health, and Euromonitor International. BioNixus is a global healthcare market research firm with Peru and South America execution capability covering pharmaceutical U&A, DIGEMID regulatory awareness, SIS/EsSalud market access intelligence, physician surveys, KOL mapping, and HEOR.
How much does healthcare market research cost in Peru?
Custom healthcare market research in Peru typically ranges from $14,000 to $50,000 per project depending on methodology, therapeutic area, and scope. Physician specialist recruitment may require longer timelines outside Lima. HEOR and market access studies typically range from $22,000 to $70,000+. Peru's relatively smaller specialist physician population compared to Brazil or Mexico can affect panel feasibility for narrow therapeutic area studies.
What is DIGEMID and why does it matter for pharmaceutical research in Peru?
DIGEMID (Dirección General de Medicamentos, Insumos y Drogas) is Peru's primary pharmaceutical regulatory authority under the Ministry of Health (MINSA). DIGEMID manages drug registration, clinical trial authorisation, and pharmacovigilance. For pharmaceutical market research, DIGEMID frameworks shape evidence requirements for product approval and EsSalud national formulary inclusion. Research partners with DIGEMID regulatory awareness generate more actionable market access intelligence for the Peruvian market.
What is EsSalud and how does it affect pharmaceutical market access in Peru?
EsSalud (Seguro Social de Salud del Perú) is Peru's social health insurer for formal-sector workers and their families, operating its own network of hospitals and clinics. EsSalud maintains a national medicines formulary and conducts its own procurement. For pharmaceutical market access, EsSalud formulary inclusion represents a significant volume opportunity. Research supporting EsSalud formulary decisions typically requires clinical effectiveness and pharmacoeconomic evidence tailored to Peru's healthcare context.
How does Peru's diverse population affect healthcare research design?
Peru has a highly diverse population spanning Spanish-speaking urban populations in Lima and coastal cities, and Quechua and Aymara-speaking communities in the highlands and Amazon regions. Healthcare research designs must account for this linguistic and cultural diversity through culturally adapted instruments, bilingual interviewers where needed, and careful geographic sampling to avoid Lima-centric bias. For patient research involving underserved highland or jungle populations, specialist ethnographic and community research methods are often required.
How do I recruit physicians for market research in Peru?
Physician recruitment in Peru is concentrated in Lima, which houses the major teaching hospitals (Hospital Nacional Arzobispo Loayza, Hospital Nacional Cayetano Heredia, Clínica Ricardo Palma) and specialist medical centres. EsSalud specialist networks and private clinic physicians in Lima also represent important recruitment pools. BioNixus maintains LATAM professional networks for physician surveys and KOL mapping that include Peru-based specialists across oncology, infectious disease, diabetes, cardiovascular, and other high-burden therapeutic areas.
What is the size of the pharmaceutical market in Peru?
The Peru pharmaceutical market is valued at over $3 billion USD and growing at approximately 7-9% annually, making it one of the fastest-growing in South America. Growth is driven by chronic disease expansion (TB, diabetes, cardiovascular, cancer), a rising middle class with increasing healthcare utilisation, and EsSalud and MINSA investment in healthcare infrastructure. The generics market is large and growing, while specialty and biologic therapies are gaining traction through EsSalud procurement and private channels.
Does BioNixus conduct healthcare research in Peru?
Yes. BioNixus is a global healthcare and market research firm with Peru and South America execution capability, serving pharmaceutical and biotech clients with pharmaceutical U&A, KOL mapping, physician surveys, DIGEMID regulatory intelligence, SIS/EsSalud market access research, HEOR, and competitive intelligence. Contact us to discuss your Peru healthcare research requirements.
Plan Healthcare Market Research in Peru
BioNixus delivers custom healthcare and pharmaceutical market research across Peru and South America — physician surveys, KOL mapping, DIGEMID regulatory intelligence, SIS/EsSalud market access research, HEOR, and competitive intelligence with bilingual Spanish-English delivery.
Request a Proposal